Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIRE: Supplementary Oxygen in Intermediate-Risk PE
NCT04003116Phase 3Completed
- Sponsor
- Ministry of Health
- Start
- Jul 2019
- Primary completion
- Apr 2022
- Modality
- GAS (Genetic analysis systems)
- Countries
- 1
01
Overview
A Phase 3 trial of oxygen gas in pulmonary embolism (PE), sponsored by Ministry of Health. Started Jul 2019; status: completed.
02
Drugs
oxygen gas
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04003116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003116.